-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Analysis of Chemical Machinery Equipment Network Market ] In recent years, China's pharmaceutical machinery and equipment industry has been growing in scale as the demand for the pharmaceutical market continues to grow.
Statistics show that the average annual growth rate of the total export delivery value of my country's pharmaceutical equipment industry has reached 23.
075%; in addition, the market scale of my country's pharmaceutical machinery and equipment industry has basically maintained a growth rate of more than 20% in the past five years.
.
It is reported that as of December 2020, the market size of my country's pharmaceutical machinery and equipment industry has reached nearly 50 billion yuan.
Chemical machinery and equipment network market analysis chemical machinery and equipmentStatistics show that the average annual growth rate of the total export delivery value of my country's pharmaceutical equipment industry has reached 23.
075%; in addition, the market scale of my country's pharmaceutical machinery and equipment industry has basically maintained a growth rate of more than 20% in the past five years.
.
It is reported that as of December 2020, the market size of my country's pharmaceutical machinery and equipment industry has reached nearly 50 billion yuan.
The status quo of my country's pharmaceutical equipment industry
The status quo of my country's pharmaceutical equipment industryAt present, China seems to have developed into a large country in the production of pharmaceutical equipment .
While the performance of related enterprises continues to improve, the market competitiveness is also constantly improving.
However, it is worth noting that from the perspective of the entire pharmaceutical industry chain, there are still many weak links in domestic pharmaceutical equipment.
First of all, my country’s pharmaceutical equipment industry started late and its development speed is slow.
Most pharmaceutical equipment companies can only provide some simple pharmaceutical equipment and spare parts, and the number of pharmaceutical equipment manufacturers and the number of product varieties are relatively small.
The technical level of pharmaceutical equipment products is relatively low.
Pharmaceutical equipment While the performance of related enterprises continues to improve, the market competitiveness is also constantly improving.
However, it is worth noting that from the perspective of the entire pharmaceutical industry chain, there are still many weak links in domestic pharmaceutical equipment.
First of all, my country’s pharmaceutical equipment industry started late and its development speed is slow.
Most pharmaceutical equipment companies can only provide some simple pharmaceutical equipment and spare parts, and the number of pharmaceutical equipment manufacturers and the number of product varieties are relatively small.
The technical level of pharmaceutical equipment products is relatively low.
Secondly, the problem of relying on imports of equipment in the upstream of our country is very prominent.
It is reported that most of the domestic biopharmaceutical equipment share is occupied by European, American and Japanese companies.
The domestic equipment is lacking in the market, the overall innovation ability of the industry is not high, and the market competitiveness is not strong.
In addition, there are still many domestic pharmaceutical equipment varieties that are intensively produced and scaled at a low level, product homogeneity is serious, and vicious competition in the low-end pharmaceutical equipment field is fierce.
It is reported that most of the domestic biopharmaceutical equipment share is occupied by European, American and Japanese companies.
The domestic equipment is lacking in the market, the overall innovation ability of the industry is not high, and the market competitiveness is not strong.
In addition, there are still many domestic pharmaceutical equipment varieties that are intensively produced and scaled at a low level, product homogeneity is serious, and vicious competition in the low-end pharmaceutical equipment field is fierce.
Therefore, in the context of the continuous development of the pharmaceutical industry, domestic pharmaceutical equipment companies need to find ways to break the "stuck neck" bottleneck to create cost-effective pharmaceutical equipment for users and reduce the burden of equipment investment.
Major pharmaceutical equipment companies are accelerating innovation
Major pharmaceutical equipment companies are accelerating innovation From the perspective of the entire pharmaceutical industry chain, although domestic pharmaceutical equipment still has many weak links.
However, it is understood that more and more domestic pharmaceutical equipment companies are increasing investment in the field of innovation, enhancing technological strength, and improving core competitiveness.
However, it is understood that more and more domestic pharmaceutical equipment companies are increasing investment in the field of innovation, enhancing technological strength, and improving core competitiveness.
For example, as a domestic pharmaceutical machinery field, Tofflon has been focusing on the pharmaceutical process, keeping up with the development of the pharmaceutical industry, paying attention to regulatory trends, and continuing to provide customers with value-added solutions, products and verification from a forward-looking perspective.
service.
It is reported that in recent years, Tofflon has attached great importance to R&D investment, and is continuously enriching its product line through its own investment in R&D, mergers and acquisitions, cooperation with powerful foreign pharmaceutical machinery manufacturers, and joint ventures.
At present, Tofflon has achieved its product line positioning through innovative R&D and the introduction of foreign innovative technologies.
service.
It is reported that in recent years, Tofflon has attached great importance to R&D investment, and is continuously enriching its product line through its own investment in R&D, mergers and acquisitions, cooperation with powerful foreign pharmaceutical machinery manufacturers, and joint ventures.
At present, Tofflon has achieved its product line positioning through innovative R&D and the introduction of foreign innovative technologies.
In addition, Chutian's tens of billions of production capacity and the fourth phase of the construction of the project are also in progress.
It is reported that the project site will build Chutian Science and Technology Innovation Center Building, Talent Center Building, *Workshop, Intelligent Chinese Medicine Workshop, Intelligent Backpack Workshop, Chutianyuan Creative Workshop, Apartment Building E Building and other R&D, manufacturing and management units and living Supporting facilities.
The total investment of the project is 1.
2-1.
6 billion yuan, and the construction is planned to be completed in 3-4 years.
After completion, it will lay a more solid foundation for Chutian Technology's R&D and innovation and the establishment of a medical equipment enterprise.
It is reported that the project site will build Chutian Science and Technology Innovation Center Building, Talent Center Building, *Workshop, Intelligent Chinese Medicine Workshop, Intelligent Backpack Workshop, Chutianyuan Creative Workshop, Apartment Building E Building and other R&D, manufacturing and management units and living Supporting facilities.
The total investment of the project is 1.
2-1.
6 billion yuan, and the construction is planned to be completed in 3-4 years.
After completion, it will lay a more solid foundation for Chutian Technology's R&D and innovation and the establishment of a medical equipment enterprise.
On the whole, in recent years, with the encouragement and support of national policies, all parts of our country have promoted the accelerated innovation, transformation and upgrading of the pharmaceutical equipment industry.
From the current point of view, my country's pharmaceutical machinery and equipment product technology has developed from simple imitation to the stage of cooperative development and independent innovation research and development, and the research and development capabilities of my country's pharmaceutical machinery and equipment industry are also constantly improving.
From the current point of view, my country's pharmaceutical machinery and equipment product technology has developed from simple imitation to the stage of cooperative development and independent innovation research and development, and the research and development capabilities of my country's pharmaceutical machinery and equipment industry are also constantly improving.
Conclusion
Conclusion In general, with the intensification of population aging, coverage of the medical insurance system and favorable policies, the entire pharmaceutical industry is showing good room for development.
In this context, as the "engine" of the pharmaceutical industry, the pharmaceutical equipment industry will also usher in good development opportunities.
However, it should be noted that various medical reform policies will also force the entire pharmaceutical industry to upgrade in the direction of innovation.
Affected by this, only by accelerating the promotion of innovation and upgrading equipment and technology in my country's pharmaceutical equipment industry to further meet the relevant innovation needs of pharmaceutical companies can it have a larger market and help the entire industry to accelerate into a golden development period.
In this context, as the "engine" of the pharmaceutical industry, the pharmaceutical equipment industry will also usher in good development opportunities.
However, it should be noted that various medical reform policies will also force the entire pharmaceutical industry to upgrade in the direction of innovation.
Affected by this, only by accelerating the promotion of innovation and upgrading equipment and technology in my country's pharmaceutical equipment industry to further meet the relevant innovation needs of pharmaceutical companies can it have a larger market and help the entire industry to accelerate into a golden development period.
Original title: With an average annual growth rate of 20% in my country's pharmaceutical equipment market, major companies are accelerating innovation
